Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: Involvement of vitronectin

Diabetes

Volumn 46, Issue 1, 1997, Pages 87-93

  Bobbink, Inge W G ^a   De Boer, Hetty C ^a   Tekelenburg, Winnie L H ^a   Banga, Jan Dirk ^a   De Groot, Philip G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VITRONECTIN;

ARTICLE; CELL ADHESION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; EXTRACELLULAR MATRIX; GLYCATION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0031022574     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.1.87     Document Type: Article

References (37)

1. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234, 1995
2. Brownlee M: Nonenzymatic glycosylation of macromolecules: prospects of pharmacologic modulation. Diabetes 41 (Suppl. 2):57-60, 1992
3. Brownlee M: Lilly Lecture 1993: glycation and diabetic complications. Diabetes 43:836-841, 1994
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Means G, Chang M: Nonenzymatic glycosylation of proteins: structure and function changes. Diabetes 31 (Suppl. 3):1-4, 1982
6. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
7. Rahbar S: An abnormal hemoglobin in red cells of diabetes. Clin Chim Acta 22:296-298, 1968
8. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA: Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41 (Suppl. 2):36-41, 1992
9. Humphries M, Mould A, Tuckwell D: Dynamic aspects of adhesion receptor function: integrins both twist and shout. BioEssays 15:391-397, 1993
10. Brownlee M, Vlassara H, Kooney T, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632, 1986
11. Kent M, Light N, Bailey A: Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro. Biochem J 225:745-752, 1985
12. Tanaka S, Avigad G, Brodsky B, Eikenberry E: Glycation induces expansion of the molecular packing of collagen. J Mol Biol 203:495-505, 1988
13. Charonis AS, Tsilbary EC: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41 (Suppl. 2):49-51, 1992
14. Tsilbary E, Charonis A, Reger L, Wohlhueter R, Furcht L: The effect of nonenzymatic glucosylation on the binding of the main noncollageneous NC1 domain of type IV collagen. J Biol Chem 263:4302-4308, 1988
15. Tarsio JF, Reger LA, Furcht LT: Decreased interaction of fibronectin, type IV collagen, and heparin due to nonenzymatic glycation: implications for diabetes mellitus. Biochemistry 26:1014-1020, 1987
16. Charonis AS, Reger LA, Dege JE, Kouzi Koliakos K, Furcht LT, Wohlhueter RM, Tsilibary EC: Laminin alterations after in vitro nonenzymatic glycosylation. Diabetes 39:807-814, 1990
17. Haitoglou CS, Tsilibary EC, Brownlee M, Charonis AS: Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J Biol Chem 267:12404-12407, 1992
18. Krantz S, Lober M, Thiele M, Teuscher E: Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation. Exp Clin Endocrinol 91:155-160, 1988
19. Federoff HJ, Lawrence D, Brownlee M: Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neunte outgrowth. Diabetes 42:509-513, 1993
20. Anderson SS, Kim Y, Tsilibary E: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 46:1359-1367, 1994
21. Crowley ST, Brownlee M, Edelstein D, Satriano JA, Mon T, Singhal PC, Schlondorff DO: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40:540-547, 1991
22. Klebe R, Bentley K, Sasser P, Schoen R: Elution of fibronectin from collagen with chaotropic agents. Exp Cell Res 130:111-117, 1980
23. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M: Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 13:281-292, 1988
24. Sodetz J, Pizzo S, McKee P: Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 252:5538-5546, 1977
25. Preissner K, Zwicker L, Muller-Berghaus G: Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum. Biochem J 243:105-111, 1987
26. Jaffe E, Nachman R, Becker C, Minick C: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745-2756, 1973
27. Willems C, Astaldi G, De Groot PG, Janssen M, Gonsalves M, Zeijlemaker W, Van Mourik J, Van Aken W: Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res 139:191-197, 1982
28. Houdijk W, De Groot PG, Nievelstein P, Sakariassen K, Sixma J: Von Willebrand factor and fibronectin but not thrombospondin are involved in platelet adhesion to the extracellular matrix of human vascular endothelial cells. Arteriosclerosis 6:24-33, 1986
29. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41:26-29, 1992
30. Kohn RR, Cerami A, Monnier VM: Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes 33:57-59, 1984
31. McFarland K, Catalando E, Day J, Thorpe R, Baynes J: Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 28:1011-1014, 1979
32. Mallia K, Hermanson G, Krohn R, Fujimoto E, Smith P: Preparation and use of a boronic acid affinity support for separation and quantification of glycosylated hemoglobins. Anal Lett 14:649-661, 1981
33. Johnson R, Metcalf P, Baker J: Fructosamine: a new approach to the estimation of serum glycosylprotein: an index of diabetic control. Clin Chim Acta 127:87-95, 1982
34. Kost C, Stuber W, Ehrlich H, Pannekoek H, Preissner K: Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. J Biol Chem 267:12098-12105, 1992
35. Declerck P, De Mol M, Alessi M, Baudner S, Paques E, Preissner K, Muller-Berghaus G, Collen D: Purification and characterization of a plasminogen activator inhibitor-1 binding protein from human plasma: identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454-15461, 1988
36. Garcia Frade L, de la Calle H, Torrado M, Lara J, Cuellar L, Garcia Avello A: Hypofibrinolysis associated with vasculopathy in non-insulin dependent diabetes mellitus. Thromb Res 59:51-59, 1990
37. Almer L, Nilsson I: On fibrinolysis in diabetes mellitus. Acta Med Scand 198:101-106, 1975